Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-008101

Chief Legal Officer acquired 41,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mazzariello Gina Chief Legal Officer 2022-02-22 Grant or award +41,000 41,000 D
Derivatives
Mazzariello Gina Chief Legal Officer 2022-02-22 Grant or award · Stock Option (right to buy) +182,000 182,000 D
Loading xslF345X03/doc4.xml…